Corban Laboratories

Corban Laboratories was a specialty pharmaceutical company headquartered in Kenilworth, New Jersey, with a primary focus on the dermatology therapeutic area. The company specialized in the marketing and distribution of prescription topical therapies designed to treat conditions such as atopic dermatitis, eczema, and various types of skin wounds. Its portfolio featured branded products like HylatopicPlus and Bionect, which utilized advanced formulations to improve skin barrier function and healing. In April 2013, Corban Laboratories was acquired by Prasco Laboratories, a leader in the authorized generics market. This acquisition enabled Prasco to significantly bolster its dermatology offerings and leverage Corban's established commercial infrastructure. Today, the legacy of Corban's products continues under the Prasco umbrella, serving patients with chronic skin conditions.